Catheter Precision, Inc.
VTAK
$3.54
$0.929235.60%
AMEX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 127.96% | 74.39% | 16.41% | -27.82% | -3.13% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 127.96% | 74.39% | 16.41% | -27.82% | -3.13% |
| Cost of Revenue | -12.50% | 120.00% | 57.14% | 66.67% | 128.57% |
| Gross Profit | 157.14% | 71.43% | 14.05% | -32.28% | -13.48% |
| SG&A Expenses | 6.19% | 31.21% | 13.52% | 4.99% | 91.73% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.54% | 33.40% | 17.43% | 3.21% | 80.59% |
| Operating Income | -4.45% | -32.11% | -17.48% | -4.73% | -86.10% |
| Income Before Tax | -51.85% | -78.28% | -271.75% | -113.80% | -167.77% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -29.34% | -51.21% | -741.26% | -113.80% | -167.77% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -21.07% | -51.21% | -741.26% | -113.80% | -167.77% |
| EBIT | -4.45% | -32.11% | -17.48% | -4.73% | -86.10% |
| EBITDA | -5.39% | -39.68% | -21.15% | -5.38% | -348.98% |
| EPS Basic | 94.40% | 90.04% | -19.54% | 29.05% | -89.66% |
| Normalized Basic EPS | 94.61% | 88.56% | 72.44% | 29.05% | -191.35% |
| EPS Diluted | 94.40% | 90.04% | -19.54% | 29.05% | -89.66% |
| Normalized Diluted EPS | 94.61% | 88.56% | 72.44% | 29.05% | -191.35% |
| Average Basic Shares Outstanding | 1,659.15% | 1,418.93% | 1,250.27% | 201.40% | 41.49% |
| Average Diluted Shares Outstanding | 1,659.15% | 1,418.93% | 1,250.27% | 201.40% | 41.49% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |